Research

Handcrafted therapies to showcase depth and complexity in neuro-regeneration. Our team balances scientific discovery with clinical application for ALS treatment.

ALS Phase I

Early data from phase studies shows safety markers in neural regeneration protocols within US clinical trials.

Biomarker Lab

New insights into early-stage Alzheimer's detection through advanced neuro-imaging and integrated protein analysis at our US facilities.

Neural Mapping

Mapping protein misfolding to identify novel therapeutic targets for ALS patients across our North American research network.

Pipeline

Advancing our candidate therapies through trials. We prioritize efficacy and safety in our mission to solve Alzheimer's and other neural disorders.

FDA Update

Our lead ALS compound received Fast Track designation, accelerating the path to advanced patient care in North America.

Research Ties

PhenoNet partners with leading North American universities to expand our Alzheimer's research and clinical platforms.

R&D Scale

We are expanding our North American labs to support larger clinical trial phases and accelerate neuro-regeneration milestones.

Support Our Mission

"Our dedication to ALS research is driven by a profound sense of urgency. At PhenoNet, we are not just analyzing data; we are fighting for time for patients and their families through advanced therapeutic science and unwavering scientific rigor in every trial."

Dr. S. Rivers

"The integration of proteomics and machine learning at PhenoNet has allowed us to identify Alzheimer’s triggers that were previously invisible. We are entering a new era of neuro-medicine that prioritizes patient outcomes above all else."

Dr. A. Chen

Research Insights FAQ

Who We Are

We are a biotech startup dedicated to developing groundbreaking therapies for ALS and Alzheimer's using advanced molecular biology and innovative neuro-regenerative techniques.

Our Clinical Trials

Our trials follow rigorous North American regulatory standards to ensure patient safety while testing the therapeutic efficacy of our lead neuro-regenerative compounds in clinical settings.

Our ALS Focus

Our ALS research specifically targets the prevention of motor neuron degradation and the restoration of synaptic connectivity within the spinal cord using novel proprietary compounds.

Funding & Alliances

We offer opportunities for strategic investment and philanthropic collaboration to accelerate our research pipelines. Our team manages every scientific milestone to ensure maximum impact for patients.

Partner with Us

Scientists and institutions interested in joint research or clinical partnerships can reach out through our contact portal for detailed collaboration discussions.

Our Lab Locations

Our primary R&D labs and clinical coordination centers are located within major biotech hubs in the North American / US region, facilitating close ties with top research universities and clinics.